Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michelle D. Wiest"'
Autor:
James M. Hoffman, Matthew H Rim, Katie J. Suda, Michelle D. Wiest, John S. Clark, Mina Tadrous, Linda M. Matusiak, Glen T. Schumock, Sandra Cuellar, Eric M Tichy
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and to predict growth in drug spending in 2021 in the United States, with a focus on the nonfederal hospital and clinic sect
Autor:
John S. Clark, Katie J. Suda, Matthew H Rim, Michelle D. Wiest, JoAnn Stubbings, Sandra Cuellar, Glen T. Schumock, Linda M. Matusiak, Robert J. Hunkler, Mina Tadrous, James M. Hoffman, Lee C. Vermeulen, Eric M Tichy
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy
Purpose To report historical patterns of pharmaceutical expenditures, to identify factors that may influence future spending, and to predict growth in drug spending in 2020 in the United States, with a focus on the nonfederal hospital and clinic sect
Autor:
Robert J. Hunkler, Katie J. Suda, Glen T. Schumock, JoAnn Stubbings, Michelle D. Wiest, Linda M. Matusiak, Edward C. Li, Lee C. Vermeulen
Publikováno v:
American Journal of Health-System Pharmacy. 74:1158-1173
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2017 in nonfederal hospitals, clinics, and overall (all sectors). Methods Drug expenditure data
Autor:
Robert J. Hunkler, Edward C. Li, Lee C. Vermeulen, Katie J. Suda, JoAnn Stubbings, Michelle D. Wiest, Linda M. Matusiak, Glen T. Schumock
Publikováno v:
American Journal of Health-System Pharmacy. 73:1058-1075
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2016 in nonfederal hospitals, clinics, and overall (all sectors). Methods Drug expenditure data
Autor:
Katie J. Suda, Lee C. Vermeulen, Linda M. Matusiak, Edward C. Li, Robert J. Hunkler, JoAnn Stubbings, Glen T. Schumock, Michelle D. Wiest
Publikováno v:
American Journal of Health-System Pharmacy. 72:717-736
Purpose An analysis of trends in U.S. pharmaceutical spending is presented, including projections for drug expenditures in nonfederal hospital and clinic settings in 2015. Methods Prescription drug expenditure data through September 2014 were obtaine
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 67(11)
The current medication-use process encompasses several steps[1][1]; however, the administration step is the most vulnerable for errors, excluding wrong-time errors, reported at a rate of 11% in hospitals.[2][2] High-risk i.v. medications with narrow